Response‐adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort
British Journal of Haematology · 2026-08 · 209 (2) · 524-533
DOI: 10.1111/bjh.70633 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 25.06.2026. Verfasst von Farina Eigendorff und 10 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Comprehensive Cancer Center Central Germany-Campus Jena, Univer…. Hauptthemen laut MEDLINE: Salvage Therapy, Central Nervous System Neoplasms, Consolidation Chemotherapy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Secondary central nervous system lymphoma (SCNSL) remains a rare but challenging manifestation of aggressive lymphomas, with limited prospective data to guide treatment decisions in the modern therapeutic era. We conducted a multicentre retrospective cohort study of 105 consecutively treated adult patients diagnosed with SCNSL between 2016 and 2024 across four German academic centres, capturing detailed treatment sequencing, response dynamics and outcome data. Median progression‐free survival (PFS) was 7.62 months (95% CI 5.34–9.90), and median overall survival (OS) was 16.62 months (95% CI 5.91–27.33). Consolidation with high‐dose chemotherapy and autologous haematopoietic stem cell transplantation (HDT‐AHSCT) was associated with significantly improved OS and PFS in univariate and multivariate analyses. Achieving complete remission prior to HDT‐AHSCT conferred with superior outcomes. In a small subset of patients with relapsed/refractory (rr) SCNSL, CD19‐directed chimeric antigen receptor T‐cell (CAR T) therapy showed favourable outcomes compared with non‐transplant salvage therapy in exploratory univariate analysis (OS HR 0.28, 95% CI 0.08–0.94, p = 0.039; PFS HR 0.37, 95% CI 0.16–0.88, p = 0.025). In this contemporary multicentre real‐world cohort, early response and consolidative HDT‐AHSCT emerged as key determinants of durable disease control, while CAR T therapy may represent a salvage strategy for selected patients. These findings provide clinically relevant benchmarks to inform risk‐adapted treatment sequencing in SCNSL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Comprehensive Cancer Center Central Germany-Campus Jena, Universitätsklinikum Jena, Jena, Germany.
- Klinik und Poliklinik für Hämatologie, Zelltherapie, Hämostaseologie und Infektiologie, Comprehensive Cancer Center Central Germany-Campus Leipzig, Universitätsklinikum Leipzig, Leipzig, Germany.
- Klinik für Hämatologie, Onkologie und Zelltherapie, Universitätsklinikum Magdeburg, Magdeburg, Germany.
- Medizinische Klinik A, Hämatologie, Hämostaseologie, Onkologie und Pneumologie, Universitätsklinikum Münster, Münster, Germany.
ORCID-Profile: Farina Eigendorff, Vanja Zeremski, Evgenii Shumilov, Ulf Schnetzke
Zitieren
APA
Eigendorff, F., Görke, F., Zeremski, V., Wollnitza, S., Shumilov, E., Lenz, G., Obstfelder, E., Hilgendorf, I., Vučinić, V., Hochhaus, A., & Schnetzke, U. (2026). Response‐adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort. British Journal of Haematology, 209(2), 524-533. https://doi.org/10.1111/bjh.70633
Vancouver
Eigendorff F, Görke F, Zeremski V, Wollnitza S, Shumilov E, Lenz G, et al. Response‐adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort. British Journal of Haematology. 2026;209(2):524-533. doi:10.1111/bjh.70633
BibTeX
@article{Eigendorff2026,
author = {Eigendorff, Farina and Görke, Fabian and Zeremski, Vanja and Wollnitza, Sophia and Shumilov, Evgenii and Lenz, Georg and Obstfelder, Ellen and Hilgendorf, Inken and Vučinić, Vladan and Hochhaus, Andreas and Schnetzke, Ulf},
title = {Response‐adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {2},
pages = {524--533},
doi = {10.1111/bjh.70633}
}
EUVIMED